Proteon Pharmaceuticals announces a strategic partnership in distribution with DuPont Animal Nutrition

The partnership will bring the emerging bacteriophage technology to poultry producers to help mitigate antimicrobial resistance.

Warsaw, September 9, 2020 – Proteon Pharmaceuticals, a Polish biotechnology company and leader in bacteriophage technology for livestock farming, announced a strategic partnership with DuPont Animal Nutrition, a business unit of DuPont Nutrition & Biosciences (DuPont) in distribution of Proteon’s innovative bacteriophage solutions. The aim of the partnership is to bring Proteon’s bacteriophage technology to poultry producers in selected countries, with the help of DuPont’s trusted and well-recognized brand. The partnership will strengthen DuPont’s product portfolio and expand Proteon’s distribution capabilities, as well as help to further mitigate antimicrobial resistance (AMR) in farming animals.

The global threat of antimicrobial resistance inspired Proteon’s development of bacteriophage technologies. Modern analytics and omics technologies have enabled the company’s scientists to screen and identify bacteriophage candidates for specific bacterial challenges in livestock farming and aquaculture. Solutions developed by Proteon have a significant impact on feed and food safety. Proteon’s innovative technology is already in use in the poultry industry in selected European and Asian markets. Farmers benefit from using Proteon’s technology, which ensures biosecurity in the waterline and improves production efficiency and quality.

“We strongly believe that bacteriophage-based products are the future of animal health and nutrition, and will help to reduce antibiotic use in livestock farming and aquaculture. Moreover, mitigating antimicrobial resistance will have a significant impact on consumer health as well.” said Jarosław Dastych, CEO, Proteon Pharmaceuticals. “We are excited to take this next step with DuPont to bring the benefits of bacteriophage technology, as a feed additive, to poultry producers globally.”

“Proteon Pharmaceuticals is a pioneer in bacteriophage technology used in animal farming. They have been developing this technology for over 10 years. It has been tested in Europe and Asia and proven in terms of efficacy and stability,” said Aart Materboer, Business Leader, DuPont Animal Nutrition. “This technology fits with our nutribiotic approach. We are pleased to add it to our range of solutions for poultry producers.”

“The main factors for initializing and establishing the partnership were the global, recognized and appreciated brand of DuPont and the solid scientific approach of Proteon’s employees, as well as our leading position among peer companies globally.” – said Nipun Gupta, Chief Commercial Officer, Proteon Pharmaceuticals.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.